Skip to main content
. Author manuscript; available in PMC: 2010 Feb 27.
Published in final edited form as: Eur Heart J. 2008 Mar 12;29(9):1096–1102. doi: 10.1093/eurheartj/ehn071

Table 1.

Unadjusted association of baseline characteristics with myeloperoxidase and soluble CD40L

MPO ≤ 884 pg/
mL (n = 762)
MPO > 884 pg/mL
(n = 762)
P-value sCD40L ≤ 989 pg/mL
(n = 762)
sCD40L > 989 pg/mL
(n = 762)
P-value
Demographics
  Age, years   61 (52, 69)   61 (53, 70) 0.60   61 (53, 70)   60 (52, 69) 0.09
    Age > 65 years 303 (39.8) 306 (40.2) 0.88 329 (43.2) 280 (36.8) 0.01
  Female 244 (32.0) 259 (34.0) 0.41 240 (31.5) 263 (34.5) 0.21

Risk factors
  Weight, kg   83 (72, 95)   83 (72, 96) 0.72   83 (72, 95)   83 (72, 97) 0.38
  Current smoker 218 (28.7) 225 (29.5) 0.72 215 (28.3) 228 (30.0) 0.46
  Diabetes 191 (25.1) 220 (28.9) 0.09 191 (25.1) 220 (28.9) 0.09
  History of hypertension 512 (67.2) 487 (63.9) 0.18 492 (64.6) 507 (66.5) 0.42
  Hypercholesterolaemia 475 (62.3) 485 (63.7) 0.60 486 (63.8) 474 (62.2) 0.52

Cardiovascular history
  Prior myocardial 303 (39.8) 294 (38.6) 0.64 287 (37.7) 310 (40.7) 0.23
  infarction
  Prior heart failure   50 (6.6)   42 (5.5) 0.39   48 (6.3)   44 (5.8) 0.67
  Prior PCI 224 (29.4) 216 (28.4) 0.65 217 (28.5) 223 (29.3) 0.73
  Prior CABG 182 (23.9) 160 (21.0) 0.18 170 (22.3) 172 (22.6) 0.90

Presenting characteristics
  Heart rate > 100 b.p.m.   26 (3.4)   55 (7.3) 0.001   46 (6.1)   35 (4.6) 0.21
  Systolic   14 (1.8)   23 (3.0) 0.13   28 (2.4)   19 (2.5) 0.87
  BP < 100 mmHg
  ST 224 (29.4) 233 (30.6) 0.62 235 (30.8) 222 (29.1) 0.47
  depression ≥ 1.0 mm

Index diagnosis MI 231 (30.3) 303 (39.8) <0.001 274 (36.0) 260 (34.1) 0.45

Data are shown as n (%) for dichotomous variables and median (25th, 75th percentile) for continuous variables.

BP, blood pressure; MI, myocardial infarction; PCI, percutaneous interventions; CABG, coronary artery bypass grafting.